Gan&Lee Pharmaceuticals. Posted 413.8 Million Yuan Net Loss in First Three Quarters of 2022

Gan&Lee Pharmaceuticals. (甘李药业股份有限公司) (603087.SH) reported a net loss of 413.8 million yuan in the first three quarters of 2022, reversing a net profit of 871.4 million yuan for the same period in the previous year.

Meanwhile, the company posted 1.2 billion yuan in revenue, down 50.6% year-on-year.

At the end of the reporting period, it had 10.4 billion yuan in total assets and 791.1 million yuan in total liabilities, with a liability-to-asset ratio of 7.6%.